Introducere. Boala cardiacă ischemică este principala cauză de deces, având o prevalenţă în creştere. Infarctul miocardic acut este o consecinţă a ischemiei miocardice acute prelungite, ce apare secundar unui dezechilibru între consumul şi aportul de oxigen la acest nivel. Prezentarea cazului. Prezentǎm cazul unui pacient în vârstǎ de 53 ani, care se adresează clinicii noastre pentru reevaluare cardiovascularǎ, fiind simptomatic prin dispnee la eforturi medii, vertij intermitent și dureri musculare predominant la nivelul membrelor inferioare. La vârsta de 36 de ani pacientul suferǎ un infarct miocardic antero-lateral, trombolizat, complicat cu anevrism apical de ventricul stâng, în evolu ie, cu apari ia insuficien ei cardiace cronice cu frac ie de ejec ie sever diminuatǎ, motiv pentru care se introduce în schema terapeuticǎ Sacubitril/Valsartan. Testarea cardiopulmonarǎ de efort oferǎ cele mai bune informa ii referitoare la capacitǎ ile func ionale, la pacientul nostru fiind realizatǎ la 6 luni, respectiv un an de la introducerea inhibitorilor ARNI. Astfel, s-a observat o îmbunǎtǎ ire a tuturor parametrilor urmǎri i pe parcursul testǎrii cardiopulmonare, o aten ie deosebitǎ fiind atribuitǎ creșterii rǎspunsului frecven ei cardiace la efort de la 113 bpm la 120 bpm (67%, 82% din valoarea prezisǎ). Concluzii. Particularitatea acestui caz constǎ în apari ia infarctului miocardic la o vârstǎ tânǎrǎ (36 de ani) la un pacient fǎrǎ antecedente heredocolaterale sau factori de risc asocia i la momentul respectiv și care, dupǎ evenimentul acut, dezvoltǎ o insuficien ǎ cardiacǎ cronicǎ severǎ cu limitǎri importante ale calitǎ ii vie ii și prognosticului pe termen lung. Introducerea ARNI (Sacubitril/Valsartan) în schema terapeuticǎ a determinat atât o ameliorare clinicǎ, cât și paraclinicǎ, la nivelul parametrilor ecocardiografici, frac ia de ejec ie crescând de la 25% la începutul tratamentului la 40% la ultima evaluare. Cuvinte cheie: infarct miocardic, testare cardiopulmonarǎ, ARNI, cardiopatie ischemicǎ, recuperare.
Introduction
Ischemic heart disease is the leading cause of death with increasing prevalence. Acute myocardial infarction is a consequence of prolonged acute myocardial ischemia, which appears secondary to an imbalance between oxygen consumption and intake at this level.
Regarding the etiology of acute coronary syndromes, complicated atheroma plaque is considered the main pathogenic substrate.
Cardiomyocyte necrosis is the result of occlusion of a large coronary artery secondary to intracoronary thrombosis which in turn complicates the evolution of a pre-existing atherosclerotic lesion.
Case report
We present the case of a male patient, aged 53 years old, admitted in the Cardiovascular Recovery Clinic for moderate dyspnea, intermittent dizziness and muscle pain predominantly in the lower limbs.
Regarding his medical history, he suffered an antero-lateral myocardial infarction due to excessive physical effort, which was trombolysed. Following the remission of the acute episode, the evolution over the next 6- The patient has both deceased parents: the mother at the age of 47 years secondary to an complicated type 2 diabetes (left lower limb amputation and sepsis), and the father at the age of 84, without associated chronic pathology. As a personal pathological background, in addition to the above, the patient has an apical aneurysm of the left ventricle and diabetic sensory-motor polyneuropathy secondary to unbalanced diabetes, in the stage of both micro and macroangiopathic complications.
Clinical examination:
l nutrition status -overweight patient ( w a i s t 1 7 1 c m , w e i g h t 8 9 k g , abdominal perimeter 113 cm, body mass index 28 kg / m2); l cardiovascular status -blood pressure 
Differential diagnosis
Considering the symptomatology of the patient described at the hospitalization, it was considered appropriate to make the differential diagnosis of dyspnea: In the case of the muscular pains in the lower limbs, the differential diagnosis is made between the following entities: Anamnesis plays an essential role in stratifying the risk and choosing the optimal therapeutic management for each case, in order to obtain the maximum benefit, both short and long term .Thus details such as (3, 4) intravenous drug use, heredocolateral history of sudden death or cardiovascular disease at a young age, the combination of the classic cardiovascular risk factors or the history of arterial or venous thrombosis guides and facilitates the diagnosis at an early stage .
(1,2,5)
Conclusion
The causes for myocardial infarction among patients aged less than 45 can be divided into 
